In Arterial hypertension abnormalities of left ventricular filling are constant and appear at an early stage, and in most cases signs of left ventricular failure (LVF) precede alterations in the left ventricular systolic function. The purpose of this study was to evaluate the frequency as well as the clinical and echocardiographic characteristics of LVF with normal systolic function in permanent arterial hypertension. 113 permanently hypertensive patients with normal left ventricular performance at echocardiography were studied clinically (functional class, congestive signs of LVF and/or presystolic gallop) and by means of echocardiographic recordings (dimensions of the left ventricle, mitral EF slope, left atrial diameter). The left ventricular wall thickness was normal (less than or equal to 11 mm) in 31 patients (group I), increased with asymmetrical septal hypertrophy in 36 patients (group II) and diffusely and symmetrically increased in 46 patients (group III). The EF slope was significantly smaller and left atrial dilatation was significantly more frequent in groups II and III than in group I. Clinical signs of LIF and presystolic gallop were observed in only groups II and III. Clinical LVF was found in 33/113 hypertensive patients (29%) and was always accompanied by symmetrical or asymmetrical left ventricular mural hypertrophy. Moreover, presystolic gallop (n = 8, i.e. 24%) and left atrial dilatation were significantly more frequent in patients with LVF than in those without LVF. Thus, LVF with normal systolic function is frequent in permanent hypertension. It results exclusively from abnormalities of left ventricular relaxation and/or compliance.
Download full-text PDF |
Source |
---|
J Cardiovasc Electrophysiol
January 2025
Department of Cardiac Electrophysiology and Pacing, Arrhythmia Heart Failure Academy, The Madras Medical Mission, Chennai, Tamil Nadu, India.
Introduction: Permanent implantation of a DF-4 implantable cardiac defibrillator (ICD) lead in the left bundle branch area (LBBA-ICD) is the next paradigm in amalgamating cardiac resynchronization therapy (CRT) and defibrillation. We systematically investigated feasibility/success rate, procedural caveats, and complications associated with a permanent DF-4 LBBA ICD implant and pertinent data at short-term follow-up.
Methods: We prospectively attempted implantation of 7 Fr Durata (Abbott, Chicago, IL, USA) single coil DF-4 ICD lead at the LBBA using a fixed-curve non-deflectable CPS locator delivery sheath.
J Biomed Mater Res B Appl Biomater
February 2025
McGowan Institute for Regenerative Medicine, Pittsburgh, Pennsylvania, USA.
Cardiovascular diseases (CVDs) were responsible for approximately 19 million deaths in 2020, marking an increase of 18.7% since 2010. Biological decellularized patches are common therapeutic solutions for CVD such as cardiac and valve defects.
View Article and Find Full Text PDFJ Clin Hypertens (Greenwich)
January 2025
Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, USA.
Essential hypertension is one of the most common conditions managed in pediatric cardiology and can result in lasting deleterious effects on the cardiovascular system. Pediatric hypertension is so prevalent in the United States that it is often referred to as a public health challenge. Social determinants of health (SDH) are the cultural, economic, educational, healthcare accessibility, and political influences in the environment in which an individual is born or lives, all of which can affect that individual's overall health.
View Article and Find Full Text PDFEchocardiography
January 2025
Cardiology Department, Unidade Local de Saúde do Alto Ave, Guimarães, Portugal.
Purpose: This study explores the effects of anthracycline chemotherapy (AC) on breast cancer patients, focusing on changes in body composition, advanced echocardiographic parameters at rest and during exercise, and biomarkers; and subsequently assesses whether these parameters are associated with impaired cardiorespiratory fitness (CRF).
Methods: In this prospective study, we evaluated women with early-stage breast cancer undergoing AC at three visits: before AC, 1 month after, and 6 months post-AC.
Results: The study included 32 women with breast cancer, with functional disability increasing from 9.
Muscle Nerve
January 2025
Stead Family Department of Pediatrics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA.
Introduction/aims: Prophylactic treatment of left ventricular dysfunction (LVD) in Duchenne muscular dystrophy (DMD) delays onset of LVD, but there is limited data showing impact on survival. Our aim was to describe survival among treated and untreated individuals with DMD.
Methods: Retrospective, population-based surveillance data from the Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet) were used.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!